Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Ravi Salgia

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Salgia, Ravi

Item TypeName
Concept Lung Neoplasms
Academic Article Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Academic Article Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.
Academic Article Molecular abnormalities in lung cancer.
Academic Article Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Academic Article Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
Academic Article Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
Academic Article ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.
Academic Article Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Academic Article Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma.
Academic Article Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Academic Article Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
Academic Article Role of receptor tyrosine kinases in lung cancer.
Academic Article Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.
Academic Article c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Academic Article Fibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancer.
Academic Article Molecular alterations in lung cancer. Impact on prognosis.
Academic Article Small cell lung cancer: from molecular biology to novel therapeutics.
Academic Article Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
Academic Article Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.
Academic Article Targeted molecules in small cell lung cancer.
Academic Article p53 and Bcl-2 in small cell-lung cancer.
Academic Article Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system.
Academic Article Phase II study of imatinib in patients with small cell lung cancer.
Academic Article A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
Academic Article Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer.
Academic Article Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.
Academic Article Novel therapies in lung cancer.
Academic Article Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells.
Academic Article A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Academic Article Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
Academic Article c-Met inhibition.
Academic Article A review of topoisomerase inhibition in lung cancer.
Academic Article c-Met: structure, functions and potential for therapeutic inhibition.
Academic Article Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors.
Academic Article Lung carcinoma in African Americans.
Academic Article Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue.
Academic Article PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Academic Article MET as a target for treatment of chest tumors.
Academic Article Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Academic Article EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
Academic Article Biology and novel therapeutics for neuroendocrine tumors of the lung.
Academic Article Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1.
Academic Article Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
Academic Article Receptor tyrosine kinases and inhibitors in lung cancer.
Academic Article Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.
Academic Article Expression and mutational analysis of MET in human solid cancers.
Academic Article Stamp out lung cancer.
Academic Article Role of c-Met in cancer: emphasis on lung cancer.
Academic Article EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
Academic Article Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.
Academic Article MET receptor tyrosine kinase.
Academic Article Ethnic differences and functional analysis of MET mutations in lung cancer.
Academic Article The role of chemokine receptor CXCR4 in lung cancer.
Academic Article CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
Academic Article Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
Academic Article The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
Academic Article Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
Academic Article Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.
Academic Article Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Academic Article Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
Academic Article Non-receptor tyrosine kinase inhibitors in lung cancer.
Academic Article Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer.
Academic Article Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Academic Article A novel classification of lung cancer into molecular subtypes.
Academic Article Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Academic Article Overexpression of the µ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
Academic Article Differential expression of RON in small and non-small cell lung cancers.
Academic Article Mind-mapping for lung cancer: towards a personalized therapeutics approach.
Academic Article Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).
Academic Article Therapeutic targeting of receptor tyrosine kinases in lung cancer.
Academic Article MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.
Academic Article Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer.
Academic Article MET and phosphorylated MET as potential biomarkers in lung cancer.
Academic Article The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.
Academic Article Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Academic Article CD14(+)S100A9(+) myeloid-derived suppressor cells portend decreased survival in patients with advanced lung cancer.
Academic Article Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions.
Academic Article Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
Academic Article Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
Academic Article The role of the c-Met pathway in lung cancer and the potential for targeted therapy.
Academic Article Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
Academic Article Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
Academic Article Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
Academic Article Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
Academic Article MET molecular mechanisms and therapies in lung cancer.
Academic Article Personalized treatment of lung cancer.
Academic Article An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancer.
Academic Article Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
Academic Article Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.
Academic Article Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
Academic Article Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.
Academic Article The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.
Academic Article Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
Academic Article Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
Academic Article Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
Academic Article Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma.
Academic Article Case 1: small bowel obstruction due to metastatic lung cancer.
Academic Article Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
Academic Article Detection and analysis of lung cancer cells from body fluids using a rare event imaging system.
Academic Article Molecular and cellular biology of small cell lung cancer.
Academic Article Unusual problems in breast cancer and a rare lung cancer case. Case 4. Primary lymphoepithelioma-like carcinoma of the lung.
Academic Article Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancer.
Academic Article Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.
Academic Article A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Academic Article Key signaling pathways and targets in lung cancer therapy.
Academic Article Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Academic Article C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes.
Academic Article Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
Academic Article Novel targets for therapeutic agents in small cell lung cancer.
Academic Article The role of EGFR inhibition in the treatment of non-small cell lung cancer.
Academic Article MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.
Academic Article Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
Academic Article Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.
Academic Article Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
Academic Article Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Academic Article Role of MetMAb (OA-5D5) in c-MET active lung malignancies.
Academic Article A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer.
Academic Article Lack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosis.
Academic Article The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Academic Article Evidence-based role of bevacizumab in non-small cell lung cancer.
Academic Article A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.
Academic Article MET as a possible target for non-small-cell lung cancer.
Academic Article Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
Academic Article Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two cases.
Academic Article Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.
Academic Article Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
Academic Article Increased µ-opioid receptor expression in metastatic lung cancer.
Academic Article The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.
Academic Article Molecular biomarkers for future screening of lung cancer.
Academic Article MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.
Academic Article Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.
Academic Article Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Academic Article Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.
Academic Article Mitochondrial dynamics: biology and therapy in lung cancer.
Academic Article Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.
Academic Article Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.
Academic Article Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.
Academic Article Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Academic Article Molecular pathways and therapeutic targets in lung cancer.
Academic Article Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.
Academic Article Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
Academic Article Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
Academic Article Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening.
Academic Article Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
Academic Article A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
Academic Article Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.
Academic Article AXL mediates resistance to cetuximab therapy.
Academic Article Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Academic Article A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
Academic Article Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Academic Article Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach.
Academic Article A new PET/CT volumetric prognostic index for non-small cell lung cancer.
Academic Article Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer.
Academic Article A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
Academic Article HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
Academic Article Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
Academic Article Lung cancer-a fractal viewpoint.
Academic Article ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
Academic Article Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
Academic Article Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.
Academic Article Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
Academic Article Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
Academic Article Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.
Academic Article Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
Academic Article 1330: Brigatinib efficacy and safety in patients (Pts) with anaplastic lymphoma kinase (ALK)-positive (ALK+) non-small cell lung cancer (NSCLC) in a phase 1/2 trial.
Academic Article Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
Academic Article Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.
Academic Article Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.
Academic Article Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Academic Article Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
Academic Article Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.
Academic Article Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Academic Article MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung Cancer.
Academic Article PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Academic Article Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer.
Academic Article DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER.
Academic Article KRAS in Non-Small-Cell Lung Cancer-Reply.
Academic Article Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterus.
Academic Article Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
Academic Article The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Academic Article Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Academic Article TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
Academic Article CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC).
Academic Article Refining epidermal growth factor receptor (EGFR) -inhibition-related rash (EIRR) phenotypes with a cetuximab (C) monotherapy stage of a phase II trial for non-small cell lung cancer (NSCLC).
Academic Article A phase 1/2 study of STA-4783 in combination with paclitaxel and carboplatin in chemo-naïve advanced non-small cell lung cancer (NSCLC).
Academic Article Phase II trial of sequential bevacizumab (B), erlotinib (E) and chemotherapy for first line treatment of clinical stage IIIB or IV non-small cell lung cancer (NSCLC).
Academic Article A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.
Academic Article Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
Academic Article Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
Academic Article MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale.
Academic Article The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy.
Academic Article Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
Academic Article Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
Academic Article Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.
Academic Article Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.
Academic Article Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Academic Article Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
Academic Article Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).
Academic Article EphB4: A promising target for upper aerodigestive malignancies.
Academic Article Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
Academic Article Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models.
Academic Article Managing Patients With Relapsed Small-Cell Lung Cancer.
Academic Article Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention.
Academic Article The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer.
Academic Article Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients.
Academic Article Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
Academic Article Heuristic value-based framework for lung cancer decision-making.
Academic Article State-of-the-art considerations in small cell lung cancer brain metastases.
Academic Article Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.
Academic Article The DNA walk and its demonstration of deterministic chaos-relevance to genomic alterations in lung cancer.
Academic Article RLIP inhibition suppresses breast-to-lung metastasis.
Academic Article Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.
Academic Article Combined Checkpoint Inhibition and Chemotherapy: New Era of 1st-Line Treatment for Non-Small-Cell Lung Cancer.
Academic Article Early mortality of stage IV non-small cell lung cancer in the United States.
Academic Article Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio.
Academic Article Targeted Therapies in Non-small-Cell Lung Cancer.
Academic Article Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.
Academic Article Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.
Academic Article Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.
Academic Article EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.
Academic Article Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells.
Academic Article Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
Academic Article Precision medicine and actionable alterations in lung cancer: A single institution experience.
Academic Article Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
Academic Article Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines.
Academic Article The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.
Academic Article Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach.
Academic Article Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites.
Academic Article Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors.
Academic Article Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies.
Academic Article Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer.
Academic Article Progressive Neurologic Changes in a Patient With Metastatic Non-Small-Cell Lung Cancer: Cancer Effects or a Secondary Diagnosis?
Academic Article Lysocardiolipin acyltransferase regulates NSCLC cell proliferation and migration by modulating mitochondrial dynamics.
Academic Article Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research.
Academic Article A Non-genetic Mechanism Involving the Integrin ß4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer.
Academic Article The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Academic Article Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.
Academic Article Erratum: A Non-genetic Mechanism Involving the Integrin ß4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer.
Academic Article Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival.
Academic Article Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report.
Academic Article Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure.
Academic Article The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC).
Academic Article Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report.
Academic Article Improving Care for Patients With Stage III or IV NSCLC: Learnings for Multidisciplinary Teams From the ACCC National Quality Survey.
Academic Article Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy.
Academic Article Disparate outcomes in nonsmall cell lung cancer by immigration status.
Academic Article RNA-based therapies: A cog in the wheel of lung cancer defense.
Academic Article Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer.
Academic Article ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation.
Academic Article Germline mutations and age at onset of lung adenocarcinoma.
Academic Article Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer.
Academic Article The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer.
Academic Article Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Academic Article Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions.
Academic Article Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer.
Academic Article Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma.
Academic Article Biologically Active Volume of Disease (BaVD) Predicts for Survival in Metastatic Non-Small Cell Lung Cancer.
Academic Article Infectious complications of immune checkpoint inhibitors in solid organ malignancies.
Academic Article Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC).
Academic Article ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready?
Academic Article The next targets for small cell lung cancer.
Academic Article Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy.
Academic Article Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients.
Academic Article Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer.
Academic Article Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Academic Article Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer.

Search Criteria
  • Lung Cancer